GENETIC TECHNOLOGIES LIMITED — Director's Dealing 2004

Nov 25, 2004

Rule 3.19A.1

Appendix 3X

Initial Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity Genetic Technologies Limited
ABN 17 009 212 328

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Robert John Edge
Date of appointment	19 April 2004

Part 1 - Director's relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Number & class of securities 500,000 unlisted options exercisable at 48 cents on or before 19April 2010 issued under the Genetic Technologies Limited Staff Share Plan

Part 2 - Director's relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest.	Number & class of Securities
Nil

⁺ See chapter 19 for defined terms.

Part 3 - Director's interests in contracts

	Detail of contract
	Nature of interest
	Name of registered holder (if issued securities)
	No. and class of securities to which interest relates

26 November 2004

$+$ See chapter 19 for defined terms.